MediBeacon Inc.
1 known investors
MediBeacon develops biocompatible fluorescent tracer agents detected by skin sensors for clinical diagnostic applications including kidney function assessment and gastrointestinal permeability measurement. The company's medical technology platform serves clinicians managing patients with kidney disease and inflammatory bowel disorders, with additional applications in surgical visualization and preclinical research.
AI & Machine LearningBiotechHealthtechMedical Devices
Investors · 1
In the news
- MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement Systemprnewswire.com · 2022
- Noninvasive, point-of-care kidney monitor startup raises $22.4M to get to market | Fierce Biotechfiercebiotech.com · 2015
- MediBeacon™ Inc. Enters into Agreement for $22.4 Million Investment to Bring Breakthrough Noninvasive Real-Time Kidney Monitoring to Market - Medibeaconmedibeacon.com · 2015